Trials | Year | Expected observed | Expected total | Controls observed | Controls total | ERR (95% CI) | ERD (95% CI) | NNT (95% CI) |
---|---|---|---|---|---|---|---|---|
Durandet al 34 | 1995 | 7 | 22 | 13 | 19 | 0.47 (0.19, 1.17) | −36.60 (−65.16, −8.04) | |
Brozanskiet al 35 | 1995 | 33 | 37 | 31 | 32 | 0.92 (0.56, 1.50) | −7.69 (−19.37, 4.00) | |
Yeh et al 38 | 1994 | 11 | 47 | 24 | 47 | 0.46 (0.22, 0.94) | −27.66 (−46.39, −8.93) | |
Kariet al 36 | 1993 | 15 | 17 | 21 | 22 | 0.92 (0.48, 1.79) | −7.22 (−24.84, 10.40) | |
Shinwellet al 31 | 1996 | 32 | 132 | 24 | 116 | 1.17 (0.69, 1.99) | 3.55 (−6.83, 13.94) | |
Rastogiet al 30 | 1996 | 5 | 32 | 21 | 32 | 0.24 (0.09, 0.63) | −50.00 (−70.71, −29.29) | |
Tapiaet al 39 | 1996 | 11 | 55 | 16 | 54 | 0.68 (0.31, 1.45) | −9.63 (−25.76, 6.50) | |
Yeh et al 33 | 1990 | 8 | 26 | 12 | 20 | 0.51 (0.21, 1.25) | −29.23 (−57.08, −1.38) | |
Pooled [χ2=37.94 (df=7)] | 122 | 368 | 62 | 342 | 0.71 (0.61, 0.84) | −11.53 (−17.17, −5.88) | 8 (5, 17) |